Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Steroid Reduces the Risk for Major Adverse Kidney Events in IgA Nephropathy
Polypharmacy May Increase Risks for Kidney Failure, Cardiovascular Events
Keytruda Approved as Adjuvant Treatment for Renal Cell Carcinoma After Surgery
Potassium Binder Fast Tracked for Reducing CV Outcomes in Chronic Hemodialysis
ACR: Risk Factors ID’d for Hydroxychloroquine-Related Retinopathy
ASN: Steroids Best Placebo in High-Risk IgA Nephropathy
FDA Clears System That Allows for Remote Endoscopy Procedures
ASN: PPI Use May Up Risk for AKI After Cardiac Surgery
Empagliflozin: Cardio-Renal Benefits in HF, LVEF Above 40% Regardless of CKD Status
Urate-Degrading Enzyme Fast Tracked for Hyperuricemia With Gout and CKD
FDA Approves Cortrophin Gel for Certain Chronic Autoimmune Disorders
RCT Data Needed on Phosphate-Lowering Agents and NDD-CKD Outcomes
Doctors Report That Kidney Grown in Pig Worked in a Human
FDA Approves Lenalidomide Capsules in 2.5mg, 20mg Strengths
CaroSpir, a Liquid Form of Spironolactone, Now Available in Unit Dose Cups
Functional Iron Deficiency Linked to CV Disease, Mortality
Phosphate Binder Dissatisfaction May Affect Patient Outcomes
Race-Free GFR Equations Based on Creatinine Plus Cystatin C More Accurate
